206 related articles for article (PubMed ID: 22811710)
1. Malignant melanoma and its stromal nonimmune microecosystem.
Piérard GE; Piérard-Franchimont C; Delvenne P
J Oncol; 2012; 2012():584219. PubMed ID: 22811710
[TBL] [Abstract][Full Text] [Related]
2. 'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.
Quatresooz P; Reginster MA; Piérard GE
Exp Ther Med; 2011 May; 2(3):379-384. PubMed ID: 22977513
[TBL] [Abstract][Full Text] [Related]
3. Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.
Piérard-Franchimont C; Hermanns-Lê T; Delvenne P; Piérard GE
Oncol Rev; 2014 Sep; 8(2):252. PubMed ID: 25992239
[TBL] [Abstract][Full Text] [Related]
4. HOX Gene Aberrant Expression in Skin Melanoma: A Review.
Piérard GE; Piérard-Franchimont C
J Skin Cancer; 2012; 2012():707260. PubMed ID: 23091727
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
6. [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma].
Wu Y; Zhang XB; Liu HJ; Zheng LD; Li JW; Lin Y
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):466-9. PubMed ID: 17845760
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
Taran JM; Heenan PJ
Cancer; 2001 May; 91(9):1822-5. PubMed ID: 11335909
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1.
Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
[TBL] [Abstract][Full Text] [Related]
11. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic status and cutaneous malignant melanoma in Northern Europe.
Idorn LW; Wulf HC
Br J Dermatol; 2014 Apr; 170(4):787-93. PubMed ID: 24359255
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
14. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
van den Hurk K; Niessen HE; Veeck J; van den Oord JJ; van Steensel MA; Zur Hausen A; van Engeland M; Winnepenninckx VJ
Biochim Biophys Acta; 2012 Aug; 1826(1):89-102. PubMed ID: 22503822
[TBL] [Abstract][Full Text] [Related]
15. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
16. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
17. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
19. Worldwide cutaneous malignant melanoma incidences analyzed by sex, age, and skin type over time (1955-2007): Is HPV infection of androgenic hair follicular melanocytes a risk factor for developing melanoma exclusively in people of European-ancestry?
Merrill SJ; Subramanian M; Godar DE
Dermatoendocrinol; 2016; 8(1):e1215391. PubMed ID: 27588159
[TBL] [Abstract][Full Text] [Related]
20. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
